Historique
Chapitre
Prescription opioid use: pain management and drug abuse in King County and Washington State
(L'usage d'opiacés sur prescription : traitement de la douleur et abus de médicaments dans le comté de King et l'état de Washington)
Auteur(s) :
BANTA-GREEN, C. ;
MERRILL, J. ;
JACKSON, T. R. ;
HANRAHAN M. ;
54th semiannual meeting of the CEWG (June 24-27, 2003; St Louis, Missouri)
Année
2004
Page(s) :
309-315
Langue(s) :
Anglais
Éditeur(s) :
Bethesda, MD : NIDA
Domaine :
Autres substances / Other substances
Thésaurus mots-clés
OPIACES
;
MEDICAMENTS
;
ABUS
;
EVOLUTION
;
METHADONE
;
BUPRENORPHINE
;
ANTALGIQUES
;
PRESCRIPTION MEDICALE
Thésaurus géographique
ETATS-UNIS
Note générale :
In : Epidemiologic trends in drug abuse, vol.2: Proceedings of the Community Epidemiology Work Group, 54th Meeting, St. Louis, Missouri, June 24-27, 2003, Bethesda, NIDA, 2004, 309-315
Résumé :
Prescription opioids provide relief to many people suffering from moderate to severe pain. Guidelines for management of pain were released in 1996 by the Washington State Medical Quality Assurance Commission. These guidelines clearly state that the undertreatment of pain has negative impacts on the public and the Commission provides physicians with specific advice for the appropriate use of opioids in the treatment of medical conditions involving substantial pain. Two prescription opioids used to control pain, methadone and buprenorphine, are also used to treat addiction to illicit or prescription opioids. While crucial to the appropriate treatment of pain, prescription opioids can be also be misused and result in harmful effects. Disentangling legitimate from illegitimate uses of these medications is complex. Recent data from several diverse sources for the Seattle-King County area and Washington State are presented in this paper. When examined together, these data highlight trends and potential consequences of local prescription opioid use. The generic and common brand names of various opioids referred to in this paper are presented. (Extract of the publication)
Affiliation :
Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA, USA